FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

New Rapid-acting Antidepressants

Kenji Hashimoto
    Product form
      FORMAT: Paperback / softback

      R 5,960.72 Price and availability exclusive to website

      YOU COULD EARN 5,960.72 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 10 - 15 Business Days
      BUY NOW PAY LATER
      From R 993.45 per month!
      3x monthly payments of R 1,986.90 with
      4x fortnightly payments of R 1,490.18 with
      ​This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists.  There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy.  The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area.  In this volume, a variety of novel pharmaceutical treatments are examined.  This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments.
      Format: Paperback / softback CONTRIBUTORS: Kenji Hashimoto EAN: 9783030797928 COUNTRY: Switzerland PAGES: WEIGHT: 256 g HEIGHT: 235 cm
      PUBLISHED BY: Springer Nature Switzerland AG DATE PUBLISHED: 2022-10-24 CITY: GENRE: MEDICAL / Neuroscience WIDTH: 155 cm SPINE:

      Book Themes:

      Psychopharmacology, Neurosciences

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      First Name – Kenji Last Name – Hashimoto Institution - Chiba University Center for Forensic Mental Health Department - Division of Clinical Neuroscience City – Chiba 260-8670 State – Chiba Country – Japan Email – hashimoto@faculty.chiba-u.jp Kenji Hashimoto, PhDChiba University, Chiba, JapanDr. Hashimoto is a professor and vice-director of Chiba University Center for Forensic Mental Health from 2005. Dr. Hashimoto graduated from Faculty of Pharmaceutical Sciences at Kyushu University, and received PhD. After Dr. Hashimoto worked at Fukuyama University, National Institutes of Health (NIH)/National Institute of Drug Addiction (NIDA)(Baltimore, MD, USA) and Pharmaceutical company, he moved at Chiba University Graduate School of Medicine from 2001. Dr. Hashimoto works on the development of novel therapeutic drugs for psychiatric and neurological disorders. Dr. Hashimoto published more than 550 articles in PubMed listed publications. Dr. Hashimoto focus on the molecular and cellular mechanisms of ketamine’s antidepressant actions.
      ​This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists.  There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy.  The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area.  In this volume, a variety of novel pharmaceutical treatments are examined.  This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments.
      Format: Paperback / softback CONTRIBUTORS: Kenji Hashimoto EAN: 9783030797928 COUNTRY: Switzerland PAGES: WEIGHT: 256 g HEIGHT: 235 cm
      PUBLISHED BY: Springer Nature Switzerland AG DATE PUBLISHED: 2022-10-24 CITY: GENRE: MEDICAL / Neuroscience WIDTH: 155 cm SPINE:

      Book Themes:

      Psychopharmacology, Neurosciences

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      First Name – Kenji Last Name – Hashimoto Institution - Chiba University Center for Forensic Mental Health Department - Division of Clinical Neuroscience City – Chiba 260-8670 State – Chiba Country – Japan Email – hashimoto@faculty.chiba-u.jp Kenji Hashimoto, PhDChiba University, Chiba, JapanDr. Hashimoto is a professor and vice-director of Chiba University Center for Forensic Mental Health from 2005. Dr. Hashimoto graduated from Faculty of Pharmaceutical Sciences at Kyushu University, and received PhD. After Dr. Hashimoto worked at Fukuyama University, National Institutes of Health (NIH)/National Institute of Drug Addiction (NIDA)(Baltimore, MD, USA) and Pharmaceutical company, he moved at Chiba University Graduate School of Medicine from 2001. Dr. Hashimoto works on the development of novel therapeutic drugs for psychiatric and neurological disorders. Dr. Hashimoto published more than 550 articles in PubMed listed publications. Dr. Hashimoto focus on the molecular and cellular mechanisms of ketamine’s antidepressant actions.

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account